Sitemap Contact

News

    See MoreSymphogen and Origen Collaborate to Produce Transgenic Chicken for generation of Fully Human Antibody Therapeutics
    See MoreSymphogen secures € 33 million financing to support clinical development of antibody products
    See MoreSymphogen acquires Receptor BioLogix's technology
  • See MoreMore news

Events

    See MoreBIT Life Sciences’ 2nd Annual World Summit of Antivirals 2009
  • July 18 - 25, 2009 Beijing
  • More events

Shortcuts

    Partners
  • See MoreMeiji Holding Co., Ltd.
  • See MoreBiovitrum
  • See MoreGenentech
    International Documents
  • See MoreBioWorld Today
  • See MoreThe Japan Times
  • SYMPHOGEN A/S
  • Elektrovej Building 375
  • 2800 Lyngby, Denmark
  • Tel. +45 4526 5050
  • Fax. +45 4526 5060
  • info@symphogen.com
  • www.symphogen.com